Kim, J. (2025). Simultaneous immunomodulation and epithelial-to-mesenchymal transition drives lung adenocarcinoma progression - processed IMC Data. Zenodo.
Cita Chicago Style (17a ed.)Kim, Junbum. Simultaneous Immunomodulation and Epithelial-to-mesenchymal Transition Drives Lung Adenocarcinoma Progression - Processed IMC Data. Zenodo, 2025.
Cita MLA (9a ed.)Kim, Junbum. Simultaneous Immunomodulation and Epithelial-to-mesenchymal Transition Drives Lung Adenocarcinoma Progression - Processed IMC Data. Zenodo, 2025.
Precaución: Estas citas no son 100% exactas.